Radiation therapy developer Proxima Therapeutics has received Food and Drug Administration clearance for the next generation of its MammoSite balloon catheter device.
The latest model incorporates new design features, including a thinner catheter shaft and a smaller balloon to deliver partial-breast irradiation to women with early stage breast cancer less invasively, according to the Alpharetta, GA-based firm. Shipments are expected to begin in the fourth quarter.
By AuntMinnie.com staff writers
September 22, 2004
Related Reading
Varian, Proxima team up for partial breast irradiation, July 7, 2004
Proxima touts MammoSite research, May 17, 2004
Proxima receives clearance for new MammoSite catheters, April 1, 2004
MammoSite RTS treats first Canadian patient, September 17, 2003
Proxima is cleared for MammoSite RTS, May 7, 2002
Copyright © 2004 AuntMinnie.com
